Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dusan Zatko"'
Autor:
Dusan Zatko, Peter Kukumberg, Jan Luha, Petra Matalova, Beata Havelkova, Jan Murin, Tomas Tesar, Martin Wawruch, Sona Wimmerova, Rashmi Shah, Gejza Wimmer
Publikováno v:
Clinical Drug Investigation. 37:1047-1054
Non-persistence with secondary preventive measures, including medications such as statins, adversely affects the prospects of successful outcomes. This study was aimed at evaluating non-persistence with statin therapy in cohorts of young and elderly
Autor:
Martin Wawruch, Dusan Zatko, Adam Hloska, Gejza Wimmer, Vasil Hricak, Jan Murin, Rashmi Shah, Tomas Tesar, Peter Kukumberg, Jan Luha
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:201-207
PURPOSE This study was aimed at evaluating the extent of non-persistence with statin therapy in elderly patients after an ischemic stroke and identifying patient-related characteristics that are risk factors for non-persistence. METHODS The evaluable
Autor:
Gejza Wimmer, Peter Kukumberg, Zoltan Kallay, Jan Luha, Rashmi Shah, Tomas Tesar, Adam Hloska, Dusan Zatko, Lenka Kuzelova, Jan Murin, Martin Wawruch
Publikováno v:
Drugs & Aging. 33:365-373
This study investigated the extent of, and patient-related characteristics for, non-persistence with antiplatelet therapy during follow-up in elderly patients after their first ischaemic non-cardioembolic stroke. A database of the largest health insu
Autor:
Peter Kukumberg, Jan Luha, Adam Hloska, Gejza Wimmer, Tomas Tesar, Rashmi Shah, Martin Wawruch, Dusan Zatko, Sona Wimmerova, Jan Murin
Publikováno v:
Aging clinical and experimental research. 29(6)
Antiplatelet therapy following a transient ischemic attack (TIA) constitutes an important secondary prevention measure. The study was aimed at evaluating the development of non-persistence with antiplatelet therapy in elderly patients after a TIA and
Autor:
Martin, Wawruch, Dusan, Zatko, Gejza, Wimmer, Jan, Luha, Vasil, Hricak, Jan, Murin, Peter, Kukumberg, Tomas, Tesar, Adam, Hloska, Rashmi, Shah
Publikováno v:
Pharmacoepidemiology and drug safety. 26(2)
This study was aimed at evaluating the extent of non-persistence with statin therapy in elderly patients after an ischemic stroke and identifying patient-related characteristics that are risk factors for non-persistence.The evaluable study cohort (n